Details

Autor(en) / Beteiligte

• Baur, François
• Beattie, David
• Beer, David
• Bentley, David
• Bradley, Michelle
• Bruce, Ian
• Charlton, Steven J
• Cuenoud, Bernard
• Ernst, Roland
• Fairhurst, Robin A
• Faller, Bernard
• Farr, David
• Keller, Thomas
• Fozard, John R
• Fullerton, Joe
• Garman, Sheila
• Hatto, Julia
• Hayden, Claire
• He, Handan
• Howes, Colin
• Janus, Diana
• Jiang, Zhengjin
• Lewis, Christine
• Loeuillet-Ritzler, Frederique
• Moser, Heinz
• Reilly, John
• Steward, Alan
• Sykes, David
• Tedaldi, Lauren
• Trifilieff, Alexandre
• Tweed, Morris
• Watson, Simon
• Wissler, Elke
• Wyss, Daniel

Titel

The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist

Ist Teil von

• Journal of medicinal chemistry, 2010-05, Vol.53 (9), p.3675-3684

Ort / Verlag

American Chemical Society

Erscheinungsjahr

2010

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Following a lipophilicity-based hypothesis, an 8-hydroxyquinolinone 2-aminoindan derived series of β2-adrenoceptor agonists have been prepared and evaluated for their potential as inhaled ultralong-acting bronchodilators. Determination of their activities at the human β2-adrenoceptor receptor showed symmetrical substitution of the 2-aminoindan moiety at the 5- and 6-positions delivered the targeted intermediate potency and intrinsic-efficacy profiles relative to a series of clinical reference β2-adrenoceptor agonists. Further assessment with an in vitro superfused electrically stimulated guinea-pig tracheal-strip assay established the onset and duration of action time courses, which could be rationalized by considering the lipophilicity, potency, and intrinsic efficacy of the compounds. From these studies the 5,6-diethylindan analogue indacaterol 1c was shown to possess a unique profile of combining a rapid onset of action with a long duration of action. Further in vivo profiling of 1c supported the long duration of action and a wide therapeutic index following administration to the lung, which led to the compound being selected as a development candidate.